Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by wittmannon Apr 10, 2017 9:19am
290 Views
Post# 26099507

RS is getting long in tooth

RS is getting long in toothToo much talk about RS,because historically they take place based on management's recommendation.Shareholders are reluctant to oppose them.It happens but it's rare.
As for you guys that don't like the RS"s I will add you do a deeper DD.They are bad only with failing company's.Pli is not one of those failing.
Secondly many institutions will not touch a company's stock if it's below $5...that's also something overlooked here.especially by novice investors.
Thirdly an expensive stock will usually(but not always) eliminate this crazy hedge fund ,short seller , nonsense we see yearly.As the outstanding shares won't be there.
In the end it won't matter much..this company will do what it sees as right...
Not what a bunch of armchair experts like us want.
Bullboard Posts